AiM One Health connects patients and communities, an open clinical & scientific network, and a governed AI core platform into one explainable, fully traceable system — turning consented data, multi-omics, and live evidence into precision decisions for the diseases that need them most: rare disease, oncology, and immune disorders. Better outcomes, accelerated research, real-world impact.
Not a single product — a clinical intelligence platform that powers Tumor Boards, Research-as-a-Service, Virtual Cell analysis, and enterprise deployment. Tumor Board is one application of the whole.
One transparent pipeline — the signature of AiM One. Every step is traceable, and a human expert steers before a Red Team challenges the consensus.
A de-identified case, genomic report, or scientific hypothesis comes in.
Multi-agent search over live evidence — PubMed, ClinicalTrials.gov, guidelines.
Findings assembled into a structured, provenance-hashed grounding store.
A multidisciplinary council of specialist agents reviews the case in parallel.
Specialists deliberate; dissent is surfaced, not smoothed over.
Positions are weighted by evidence strength into a coherent recommendation.
A clinician steers, corrects, and directs — you stay in control of the call.
An adversarial agent tries to refute the consensus before you ever see it.
Optional computational validation of the biological mechanism at play.
A transparent, cited, audit-ready report you can trace, defend, and act on.
We don’t sell AI agents. We deliver the one thing that matters at the point of care: a decision you can stand behind.
| Traditional AI | AiM One Clinical Intelligence |
|---|---|
| Generates answers | Produces structured clinical reasoning |
| Single LLM | Multidisciplinary AI council |
| Limited citations | Comprehensive evidence synthesis |
| No challenge process | Built-in Red Team validation |
| Static recommendations | Continuous refinement with human oversight |
| Limited biological context | Optional Virtual Cell validation |
| Generic chatbot | Specialty-specific clinical intelligence |
Oncology today — and a growing catalog of specialty councils tomorrow. Each service brings the full platform to a domain.
Tumor boards & treatment strategy
Complex neuro & neuro-onc cases
CHF, ACS & arrhythmia pathways
Multidisciplinary evidence, fast
Variant interpretation & reporting
Eligibility-scored trial matching
Mechanistic simulation & validation
New councils — expanding
Every request returns a structured deliverable — so you know exactly what you get before you ever commit to a platform deployment.
The recommendation, up front.
The full deliberation, in the open.
Every source, cited & linked.
Scored against national guidelines.
Options weighed with trade-offs.
Ranked, eligibility-scored trials.
Interpretation with provenance.
Mechanistic validation, optional.
How sure — and where it’s not.
Every step, defensibly logged.
Wherever a hard question meets a high-stakes decision, AiM One fits the work you already do.
Prepare a Tumor Board
Interpret Variants
Support Translational Research
Understand Disease Biology
Accelerate Protocol Development
Evaluate Treatment Options
Generate Multidisciplinary Evidence
Deploy Enterprise Intelligence
Health systems and vendors can build directly on the platform. Programmatic access to the same council, evidence, and validation.
Submit a case, receive a structured, cited report.
Convene a multidisciplinary council on demand.
Interpret variants with full provenance.
Generate evidence synthesis programmatically.
Run mechanistic simulation & validation.
Eligibility-scored, ranked trial matching.
Historically, multidisciplinary deliberation has only been available to a small percentage of patients. AiM One Health extends coordinated clinical intelligence to every patient — serving oncology today, and expanding into every specialty tomorrow.
Each validated decision contributes to a continuously improving ecosystem of operational and clinical intelligence across participating care networks. The more institutions that join, the smarter every member becomes — and every patient benefits.
For the first time, I have a tool that lets me model the decision before I make it — and walks me through the evidence at the same time. My residents are learning faster, my patients are safer, and I'm home for dinner. That's three wins from one platform.
The architecture, the philosophy, and the clinical evidence behind AiM — in formats built for serious readers.
Recursive Outcome Loop architecture, Deep Brain orchestration, and multi-agent governance — in depth.
Browse library ArticlesField notes on multi-agent clinical simulation, MedBoard deployments, and the future of multidisciplinary care.
Read the blog Live + replayLive walkthroughs of AiM in action, AMAs with our clinical informatics team, and panels with health-system partners.
See upcoming SlidesHIMSS, HLTH, and ASCO presentations on collective intelligence engineering and the future of multidisciplinary care.
Download decksUpload a de-identified case, genomic report, research question, or scientific hypothesis — and receive a multidisciplinary Clinical Intelligence Report. No software to buy. Experience AiM One before you ever commit to a deployment.
Tell us a bit about your organization and we’ll set up a 30-minute walkthrough.
Thanks — the AiM One Health team will be in touch within one business day.